TN2011000091A1 - N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b - Google Patents

N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b

Info

Publication number
TN2011000091A1
TN2011000091A1 TN2011000091A TN2011000091A TN2011000091A1 TN 2011000091 A1 TN2011000091 A1 TN 2011000091A1 TN 2011000091 A TN2011000091 A TN 2011000091A TN 2011000091 A TN2011000091 A TN 2011000091A TN 2011000091 A1 TN2011000091 A1 TN 2011000091A1
Authority
TN
Tunisia
Prior art keywords
aminophenyl
benzamide
pyridine
polymorph
methoxycarbonyl
Prior art date
Application number
TN2011000091A
Other languages
French (fr)
Inventor
Michael Gottfried
Matthias Schneider
Jens Geisler
Gabriele Winter
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/006381 external-priority patent/WO2010022988A1/en
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of TN2011000091A1 publication Critical patent/TN2011000091A1/en

Links

Abstract

The crystalline Polymorph B of N-(2-aminophenyl)-4-[N-(pyridine-3-yl)methoxy- carbonyaminomethyl]benzamide (MS-275) of formula (I) is described, as well as the process for the production of said compound, and its use as a medicament for the treatment of selected diseases.
TN2011000091A 2009-08-27 2011-02-23 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b TN2011000091A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/006381 WO2010022988A1 (en) 2008-08-29 2009-08-27 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b

Publications (1)

Publication Number Publication Date
TN2011000091A1 true TN2011000091A1 (en) 2012-09-05

Family

ID=55024390

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000091A TN2011000091A1 (en) 2009-08-27 2011-02-23 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b

Country Status (1)

Country Link
TN (1) TN2011000091A1 (en)

Similar Documents

Publication Publication Date Title
MY149058A (en) N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b
TW201612158A (en) Amide derivatives and salts thereof, preparation process and pharmaceutical use thereof
MX2014001595A (en) Indazole compounds, compositions and methods of use.
WO2008011131A3 (en) Amide compounds
MX2012012952A (en) 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds.
NZ601121A (en) 5-alkynyl-pyrimidines
GEP201606532B (en) Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
AU2011286276A8 (en) Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases
NZ596783A (en) Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
MX2015007796A (en) Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration.
MX341565B (en) 3-amino-pyridines as gpbar1 agonists.
PH12014501417A1 (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
MX2010008460A (en) Thiazole derivative and use thereof as vap-1 inhibitor.
EA201300250A1 (en) OXADIAZOL INHIBITORS OF LEUKOTRIEN PRODUCTION
MX2013008056A (en) 1,4-oxazepines as bace1 and/or bace2 inhibitors.
GEP20156319B (en) Asymmetric ureas and medical uses thereof
IN2012DN01273A (en)
MX2013002851A (en) Inhibitors of notum pectinacetylesterase and methods of their use.
NZ596000A (en) Carboxamide compounds and their use as calpain inhibitors
WO2011107608A8 (en) Heterocyclic amides as rock inhibitors
WO2008131946A3 (en) Substituted amide derivatives
IN2012DN02502A (en)
MX364400B (en) Tetracycline compounds.
MX342153B (en) Compounds for the treatment and prophylaxis of respiratory syncytial virus disease.
MX2013003202A (en) Oxadiazole inhibitors of leukotriene production.